These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6107566)

  • 21. Evaluation of the effect of betapropiolactone/ultraviolet irradiation (BPL/UV) treatment of source plasma on hepatitis transmission by factor IX complex in chimpanzees.
    Prince AM; Stephan W; Brotman B; van den Ende MC
    Thromb Haemost; 1980 Dec; 44(3):138-42. PubMed ID: 7466740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of beta-propiolactone on routine biochemical investigations.
    Dooley BJ; Harling NP; Lloyd G; van Heyningen C
    Med Lab Sci; 1985 Oct; 42(4):318-21. PubMed ID: 4079681
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of beta-propiolactone in blood on routine haematological, biochemical, and serological investigations.
    Freeman R; Codd AA; Selkon JB
    Lancet; 1982 May; 1(8280):1048-9. PubMed ID: 6122856
    [No Abstract]   [Full Text] [Related]  

  • 24. [Potency studies of sample rabies vaccine, inactivated by beta-propiolactone].
    Akan E
    Turk Hij Tecr Biyol Derg (1961); 1976; 36(2):172-88. PubMed ID: 1023462
    [No Abstract]   [Full Text] [Related]  

  • 25. Inactivation of retroviruses by beta-propiolactone.
    Lancet; 1985 Jan; 1(8419):56. PubMed ID: 2856986
    [No Abstract]   [Full Text] [Related]  

  • 26. Inactivation of Newcastle disease virus by beta-propiolactone.
    Garlick B; Avery RJ
    Arch Virol; 1976; 52(1-2):175-9. PubMed ID: 999518
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of thrombogenicity of beta-propiolactone/ultraviolet (beta-PL/UV) treated PPSB in chimpanzees.
    Kotitschke R; Stephan W; Prince AM; Brotman B
    Thromb Res; 1983 May; 30(3):235-44. PubMed ID: 6868023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of beta-propiolactone on some routine haematological tests.
    Atrah HI; Allardyce M; Davidson RJ
    Med Lab Sci; 1988 Oct; 45(4):308-11. PubMed ID: 3268715
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of beta-propiolactone on human red cell antigens and antibodies.
    Kalish RI; Linden JV; Tweedy CJ
    Transfusion; 1987; 27(2):214-5. PubMed ID: 3824485
    [No Abstract]   [Full Text] [Related]  

  • 30. [Beta-propiolactone for cold sterilization of heart valve transplants].
    Wutzler P; Sprössig M; Wenzel KP; Mücke H
    Z Exp Chir; 1975; 8(4):236-40. PubMed ID: 1053182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivation of HIV in plasma derivatives by beta-propiolactone and UV irradiation.
    Dichtelmüller H; Stephan W; Prince AM; Gürtler L; Deinhardt F
    Infection; 1987; 15(5):367-9. PubMed ID: 3121517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cultivation of mycoplasma in fluid media sterilized with beta-propiolactone].
    Kiuntsel' V; Starost E; Meissner Kh
    Vestn Akad Med Nauk SSSR; 1976; (5):60-2. PubMed ID: 969882
    [No Abstract]   [Full Text] [Related]  

  • 33. The study of a Salmonella typhimurium vaccine inactivated with beta-propiolactone.
    Dimache G; Dimache V; Croitoru M; Ciordaş C
    Arch Roum Pathol Exp Microbiol; 1983; 42(1):53-7. PubMed ID: 6400741
    [No Abstract]   [Full Text] [Related]  

  • 34. [Beta-propiolactone as a sterilizing agent in the manufacture of intravenous immunoglobulin preparations].
    Stephan W; Dichtelmüller H
    Arzneimittelforschung; 1983; 33(9):1230-1. PubMed ID: 6416260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of ethyl alcohol and beta-propiolactone inactivated vaccinia virus on the development of skin immunity and the production of hemagglutination inhibiting antibodies in guinea pigs, rabbits and monkeys.
    Lybing S; Hedström KG
    Z Immunitatsforsch Exp Klin Immunol; 1975 May; 149(1):37-60. PubMed ID: 127456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Human i.v. immune globulin by chemical modification with beta-propiolactone/radiochemical study (author's transl)].
    Stephan W; Fasold H
    Arzneimittelforschung; 1980; 30(12):2090-3. PubMed ID: 7194066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of beta-propiolactone and ultraviolet irradiation for the treatment of viral contamination of canine serum.
    Yoshimura M; Higashihara M; Masu S
    Kitasato Arch Exp Med; 1967 Dec; 40(1):57-67. PubMed ID: 4303329
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of beta-propiolactone and ultraviolet irradiation on fibrinogen and factor 8.
    Sgouris JT
    Vox Sang; 1969 Jul; 17(1):61. PubMed ID: 5798763
    [No Abstract]   [Full Text] [Related]  

  • 39. [Principles of selective inactivation of the viral genome. III. Kinetics of the inactivation of bacteriophage MS2 infectivity by beta-propiolactone].
    Budovskiĭ EI; Zalesskaia MA
    Mol Biol (Mosk); 1985; 19(4):1139-47. PubMed ID: 4047036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the inactivation and antigenicity of foot-and-mouth-disease virus by acetylethyleneimine and by combined effect of ultraviolet light and beta-propiolactone.
    Fellowes ON
    J Immunol; 1965 Dec; 95(6):1100-6. PubMed ID: 4285068
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.